Rotella Capital Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Rotella Capital Management’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,040	Closed	-$60K	–	715
2015 Q2	$60K	Buy	2,040 +20	+1%	+$604	0.05%	355
2015 Q1	$56K	Buy	+2,020	New	+$49K	0.05%	446

Other funds holding IPCI

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

NCCM

Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Rotella Capital Management's IPCI Position: Q3 2015 in Review

Rotella Capital Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2015, closing a stake of 2,040 shares — an estimated $60K sold.

Rotella Capital Management first reported a position in IPCI in Q1 2015 and held it in 2 quarters. The position peaked at $60K in Q2 2015. 18 funds tracked by Wall St. Rank hold IPCI as of Q3 2015.

Rotella Capital Management reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2015 after selling out during the quarter.
Rotella Capital Management sold 2,040 Intellipharmaceuticals International Inc. shares in Q3 2015, an estimated $60K.
Rotella Capital Management first reported a position in Intellipharmaceuticals International Inc. in Q1 2015 and held it in 2 quarters.
Rotella Capital Management's Intellipharmaceuticals International Inc. position peaked at $60K in Q2 2015.
18 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.